• shutterstock_1151765522_slideshow_accelero.jpg

Non-clinical drug development can be divided into three subsections:

(1) Early-phase R&D development of the drug substance as well as it´s drug product formulation
(2) Non-clinical development for which GLP is not required, and
(3) Non-clinical development which indeed should comply with GLP regulations. 

The European Medicines Agency (EMA) and the European Union provide different guidances for non-clinical development, depending on the type of therapeutic the applicant would like to develop:

(1) ICH M3 (R2) Non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals.
(2) ICH S6 (R1) Preclinical safety evaluation of biotechnology-derived pharmaceuticals [expressed in host organisms].
(3) ICH S9 Non-clinical evaluation for anticancer pharmaceuticals.
(4) REGULATION (EC) No 1394/2007 on advanced therapy medicinal products [ATMPs].


Accelero Bioanalytics supports your project at all development stages. Particularly with regards to the setup and validation of quantitative pharmacokinetic test methods, Accelero can add a value to your project by conducting:

  • Early pharmacology profiling in the course of the method setup
  • Pharmacokinetic profiling in dose range finding studies for single dose and/or repeated dose (no GLP is required);
  • Formulation analysis to support dose range finding studies (no GLP is required);
  • Toxicokinetic profiling in non-clinical repeated dose toxicology studies (GLP is required);
  • Formulation analysis to support toxicology studies (GLP is required);
  • Biodistribution qPCR studies of genetically modified therapeutics or cell-based therapeutics (GLP can be a requirement).

All test methods are validated according to the EMA Guideline on bioanalytical method validation, 21 July 2011.
EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr. 2**
Accelero conducts validation studies in the spirit of the principles of Good Laboratory Practice (GLP). Test methods being applied for non-clinical pharmacology studies not required to be performed to GLP will be validated fit for purpose.



Last update of this site: 24-OCT-2016 by Christian Lange

Cookies user preferences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics